|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
03/22/2024 |
$0.08 |
$0.08 |
$0.07 |
$0.07 |
57.46M | 03/25/2024 |
$0.08 |
$0.08 |
$0.07 |
$0.07 |
34.09M | 03/26/2024 |
$0.07 |
$0.07 |
$0.07 |
$0.07 |
42.14M | 03/27/2024 |
$0.07 |
$0.07 |
$0.07 |
$0.07 |
30.56M | 03/28/2024 |
$0.07 |
$0.09 |
$0.07 |
$0.09 |
60.53M |
|
Jaguar Health is a pharmaceuticals company that develops plant-based, sustainably derived prescription medicines for people and animals with gastrointestinal distress, such as chronic, debilitating diarrhea. Co.'s subsidiary, Napo Pharmaceuticals, Inc. (Napo), develops and commercializes proprietary plant-based human pharmaceuticals. Napo's marketed drug Mytesi (crofelemer 125 mg delayed-release tablets) is an oral botanical drug product for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. Co.'s Canalevia-CA1 (crofelemer delayed-release tablets) drug is an oral plant-based prescription product to treat chemotherapy-induced diarrhea in dogs. | |
|
Jaguar Health (JAGX) has the following price history information. Looking back at JAGX historical stock prices for the last five trading days, on March 22, 2024, JAGX opened at $0.08, traded as high as $0.08 and as low as $0.07, and closed at $0.07. Trading volume was a total of 57.46M shares. On March 25, 2024, JAGX opened at $0.08, traded as high as $0.08 and as low as $0.07, and closed at $0.07. Trading volume was a total of 34.09M shares. On March 26, 2024, JAGX opened at $0.07, traded as high as $0.07 and as low as $0.07, and closed at $0.07. Trading volume was a total of 42.14M shares. On March 27, 2024, JAGX opened at $0.07, traded as high as $0.07 and as low as $0.07, and closed at $0.07. Trading volume was a total of 30.56M shares. On March 28, 2024, JAGX opened at $0.07, traded as high as $0.09 and as low as $0.07, and closed at $0.09. Trading volume was a total of 60.53M shares.
JAGX Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Jaguar Health shares, starting with a $10,000 purchase of JAGX, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
05/13/2015 |
|
End date: |
03/28/2024 |
|
Start price/share: |
$160,177.50 |
|
End price/share: |
$0.09 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-100.00% |
|
Average Annual Total Return: |
-80.22% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$0.01 |
|
Years: |
8.88 |
|
|
|
Date |
Close |
03/22/2024 | $0.07 | 03/25/2024 | $0.07 | 03/26/2024 | $0.07 | 03/27/2024 | $0.07 | 03/28/2024 | $0.09 |
|
|